SCHEMBL29460235

SCHEMBL29460235

O=C(O)c1ccc2c(c1)Cc1ccccc1-2

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SRD5A2 P31213 5/20 1.00
▸ SRD5A1 P18405 4/20 0.74
▸ HTR2C P28335 2/20 0.62
▸ HTR2B P41595 2/20 0.62
▸ DRD2 P14416 1/20 0.62
▸ ADRA1D P25100 1/20 0.62
▸ HTR2A P28223 1/20 0.62
▸ HTR7 P34969 1/20 0.62
▸ ADRA1A P35348 1/20 0.62
▸ ADRA1B P35368 1/20 0.62
▸ ALDH1A1 P00352 3/20 0.62
▸ CYP1A2 P05177 2/20 0.62
▸ HPGD P15428 2/20 0.62
▸ RAB9A P51151 3/20 0.56
▸ NPC1 O15118 2/20 0.56
▸ MAPT P10636 2/20 0.56
▸ TTR P02766 1/20 0.55
▸ PTPRC P08575 2/20 0.53
▸ ADRA2A P08913 1/20 0.53
▸ MAOA P21397 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL503767 1.00 SRD5A2 (1.00) SRD5A2SRD5A1HTR2CHTR2BDRD2
Cyanide SCHEMBL11194392 0.95 SRD5A2 (0.90) SRD5A2SRD5A1HTR2CHTR2BDRD2
SCHEMBL31069845 0.93 SRD5A2 (0.86) SRD5A2SRD5A1HTR2CHTR2BDRD2
SCHEMBL29709873 0.93 SRD5A2 (0.86) SRD5A2SRD5A1HTR2CHTR2BDRD2
SCHEMBL3105349 0.93 SRD5A2 (0.86) SRD5A2SRD5A1HTR2CHTR2BDRD2
SCHEMBL16126108 0.91 SRD5A2 (0.84) SRD5A2SRD5A1HTR2CHTR2BDRD2
SCHEMBL28119578 0.91 SRD5A2 (0.83) SRD5A2SRD5A1HTR2CHTR2BDRD2
SCHEMBL31456551 0.90 SRD5A2 (0.81) SRD5A2SRD5A1HTR2CHTR2BDRD2
SCHEMBL27506 0.90 SRD5A2 (0.81) SRD5A2SRD5A1HTR2CHTR2BDRD2
SCHEMBL30976964 0.89 SRD5A2 (0.79) SRD5A2SRD5A1HTR2CHTR2BDRD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3953350-A1 D3 RECEPTOR AGONIST COMPOUNDS; METHODS OF PREPARATION; INTERMEDIATES THEREOF; AND METHODS OF USE THEREOF The United States of America, as Represented by The Department of Health and Human Services (US) 2022-02-16 — — EP disclosed
Send feedback